FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
Pharmabiz22h
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...
Yahoo Malaysia23h
This celebrity-approved SLBA anti-aging eye treatment is 40% off ahead of Black Friday — 'it really works,' say shoppers
Aging is undoubtedly a natural part of life, and while some embrace what time does to their skin, others might look for a little something to smooth out those effects. One popular item that shoppers ...